Medical Developments International Limited (ASX:MVP)
Australia · Delayed Price · Currency is AUD 0.4750
0.00 (0.00%)
Aug 21, 2026, 4:10 PM AEST
ASX:MVP Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 42.57 | 39.06 | 33.15 | 32.34 | 21.94 | |
Revenue Growth | 8.99% | 17.82% | 2.51% | 47.37% | -13.17% |
Cost of Revenue | 11.9 | 9.63 | 8.78 | 10.13 | 6.74 |
Gross Profit | 30.67 | 29.43 | 24.37 | 22.21 | 15.21 |
Selling, General & Admin | 25.6 | 26.08 | 35.09 | 36.4 | 24.81 |
Operating Expenses | 28.29 | 29.29 | 38.49 | 39.52 | 27.75 |
Operating Income | 2.39 | 0.14 | -14.12 | -17.3 | -12.55 |
Interest Expense | -0.07 | -0.08 | -0.09 | -0.1 | -0.1 |
Interest & Investment Income | 0.42 | 0.38 | 0.4 | 0.66 | 0.47 |
Other Non Operating Income (Expenses) | -2.23 | -0.28 | -2.75 | -2.97 | -3.15 |
EBT Excluding Unusual Items | 0.5 | 0.17 | -16.55 | -19.71 | -15.33 |
Merger & Restructuring Charges | - | - | -15.8 | -6.71 | - |
Impairment of Goodwill | - | - | - | - | -0.58 |
Asset Writedown | - | - | -0.57 | - | - |
Other Unusual Items | - | - | - | 18.93 | - |
Pretax Income | 0.5 | 0.17 | -32.93 | -7.49 | -15.91 |
Income Tax Expense | -0.12 | 0.07 | 8.07 | -1.88 | -3.5 |
Net Income | 0.63 | 0.09 | -40.99 | -5.61 | -12.41 |
Net Income to Common | 0.63 | 0.09 | -40.99 | -5.61 | -12.41 |
Net Income Growth | 565.96% | - | - | - | - |
Shares Outstanding (Basic) | 112 | 110 | 86 | 84 | 71 |
Shares Outstanding (Diluted) | 118 | 112 | 86 | 84 | 71 |
Shares Change | 5.31% | 29.95% | 2.41% | 18.23% | 4.11% |
EPS (Basic) | 0.01 | 0.00 | -0.47 | -0.07 | -0.17 |
EPS (Diluted) | 0.01 | 0.00 | -0.47 | -0.07 | -0.17 |
EPS Growth | 562.50% | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 5.27 | -0.49 | -11.57 | -18.28 | -11.98 |
Free Cash Flow Per Share | 0.04 | -0.00 | -0.13 | -0.22 | -0.17 |
Gross Margin | 72.05% | 75.35% | 73.50% | 68.69% | 69.31% |
Operating Margin | 5.61% | 0.36% | -42.60% | -53.51% | -57.17% |
Profit Margin | 1.47% | 0.24% | -123.66% | -17.34% | -56.54% |
Free Cash Flow Margin | 12.38% | -1.24% | -34.91% | -56.53% | -54.58% |
EBITDA | 5.07 | 1.67 | -12.43 | -15.89 | -11.35 |
EBITDA Margin | 11.91% | 4.29% | -37.50% | -49.14% | -51.72% |
D&A For EBITDA | 2.69 | 1.53 | 1.69 | 1.41 | 1.2 |
EBIT | 2.39 | 0.14 | -14.12 | -17.3 | -12.55 |
EBIT Margin | 5.61% | 0.36% | -42.59% | -53.51% | -57.17% |
Effective Tax Rate | - | 44.05% | - | - | - |